VC and Investment
Today's issue
Refine Search
Latest VC and Investment News & Features
Pharmaceutical
EUROAPI, a company spun out from Sanofi (Euronext: SAN) in 2022, has agreed a funding plan with the French vaccines major. 28 June 2024
Biotechnology
TwoStep Therapeutics, a biotech start-up developing targeted therapies for solid tumors, has officially launched after securing $6.5 million in seed funding. 27 June 2024
Pharmaceutical
CASI Pharmaceuticals (Nasdaq: CASI) has announced a preliminary proposal from its chairman and chief executive, Wei-Wu He, to acquire the company's business operations in China. 27 June 2024
Biotechnology
AI-focused start-up Formation Bio has raised $372 million in a series D financing. 27 June 2024
Pharmaceutical
NeuroBo Pharmaceuticals (Nasdaq: NRBO), a clinical-stage biotechnology company focused on cardiometabolic diseases, has raised around $70 million through a private share placement. 26 June 2024
Pharmaceutical
In a filing with the US Securities and Exchange Commission (SEC), Californian biotech Alumis has revealed it aims to raise around $300 million in its upcoming initial public offering (IPO). 25 June 2024
Pharmaceutical
Deal volume was up 20% in the pharmaceutical and life sciences sector in the last 12 months as dealmakers grew more comfortable with uncertainty, according to a 21 June 2024
Biotechnology
London-based life science investor Syncona has added two companies to its portfolio, iOnctura and Yellowstone Biosciences. 20 June 2024
Generics
Kotak to part finance Matrix Pharma's acquisition of Viatris' API biz 19 June 2024
Biotechnology
Marea Therapeutics launches with $190 million financing 19 June 2024
Biotechnology
Private biotech rebounds with 46% growth in venture funding during 1st-qtr of 2024 19 June 2024
Biotechnology
Elion Therapeutics, a biotechnology company focusing on invasive fungal infections, has announced the successful closing of an $81 million series B funding roun 17 June 2024
Biotechnology
Opthea raises $113.2 million to fund eye drug development 15 June 2024
Biotechnology
Avidity Biosciences, a biopharmaceutical company specializing in RNA therapeutics, has announced a public share offering, with the goal of raising $400 million. 14 June 2024
Biotechnology
Santa Ana Bio emerges from stealth with $168 million financing 14 June 2024
Pharmaceutical
Alzheon, a clinical-stage biopharma company, has secured $100 million in a series E funding round led by Alerce Medical Technology Partners. 13 June 2024
Series C
Aardvark Therapeutics might not have scored the biggest venture haul in May, but its $85 million Series C round will further strengthen rumors that the Californ 13 June 2024
Biotechnology
Bright Peak secures $90 million in Series C financing 12 June 2024
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze